Laboratory assessment of prostate status

Area of Science:

• Oncology
• Biochemistry
• Medical Diagnostics

Background:

• Prostate cancer diagnosis and monitoring rely on specific biomarkers.
• Current single-marker approaches may have limitations in sensitivity and patient stratification.

Purpose of the Study:

• To evaluate the diagnostic and monitoring advantages of a combined Prostate-Specific Antigen (PSA) and Prostate-Alkaline Phosphatase (PAP) assay.
• To assess the enhanced sensitivity and objective follow-up parameters offered by dual biomarker testing.

Main Methods:

• Comparative analysis of PSA and PAP levels in patient cohorts.
• Assessment of detection sensitivity using combined versus individual marker assays.
• Evaluation of objective parameters for patient monitoring.

Main Results:

• Combined PSA and PAP measurement demonstrated increased sensitivity for prostate cancer detection.
• The dual marker strategy provided a greater number of patients with objective parameters for effective follow-up.

Conclusions:

• Combining PSA and PAP measurements offers a significant advantage in diagnostic sensitivity.
• Dual biomarker monitoring enhances objective follow-up for patients with prostate carcinoma, improving clinical management.